Most recent PMH Capital articles, videos and podcasts

Inspiration Healthcare secures $4.3m contract for neonatal ventilators, sets stage for long-term growth

Inspiration Healthcare has secured a $4.3m contract for neonatal ventilators and related equipment, marking its largest single order and positioning the company for future growth.

Eleco reports record growth in recurring revenues for H1, driven by strong demand and strategic acquisitions

2 days ago

Eleco reports a strong first half of 2024, with a 31% increase in annualised recurring revenue and a 12% LFL rise in total revenue, reflecting continued growth and successful integration of recent acquisitions.

Verici Dx sees revenue surge to $3.3m in H1, on track to be profitable by 2025

12 days ago

Verici Dx's half-year report showcases substantial revenue growth and strategic advancements in organ transplant diagnostics, reinforcing its position as a leader in the field.

Mpac Group reports strong H1 performance, confirms positive full-year outlook

17 days ago

Mpac Group reports strong first half results, with profits significantly higher than last year's, and optimistic in-line projections for FY24.

Equals receives enhanced offer from TowerBrook and Railsr, PUSU deadline extended until August 7, 2024

17 days ago

Equals receives an enhanced offer from TowerBrook Capital and Railsr of 135p/share for the group, prompting an extension of the PUSU deadline for further evaluation.

Finseta reports strong interim performance, expects significant growth in FY24

18 days ago

Finseta announces strong performance in H1 2024, marked by robust revenue growth and enhanced profitability. With notable growth in active customers, improved gross margins, and substantial cashflow generation, the company is well-positioned for continued expansion in FY24.

Equals sees strong revenue growth, strategic review nears conclusion

24 days ago

The pieces in the Equals jigsaw are falling perfectly into place. Indeed today the company released an eye-popping trading update. Saying H1'24 revenues had soared 33% to £59.96m (vs £45.0m LY) - with an exit Q2’24 run-rate of £32.6m (+40% YoY), equivalent to £527k per working day.

Belluscura Raises £1.92m in funding to boost Portable Oxygen Concentrator commercialisation

25 days ago

Subject to shareholder approval on 8th July, Belluscura has just raised a further £1.92m to help fully commercialise its next generation portable oxygen concentrators (POCs).

Fadel appoints Simon Wilson as Chairman to drive international growth

25 days ago

Today's news from IP management, brand compliance, and media content software provider Fadel, which has appointed Simon Wilson as its Chairman. Simon is an experienced software executive, with current board positions at SurfControl, Endace, and PCI Pal plc.

Supreme's robust cash generation and profit growth defy market challenges

25 days ago

The beauty of investing in rapidly expanding fast moving consumer goods stocks like Supreme is their double digit organic growth, expanding profit margins & robust cash generation.

Verici Dx celebrates significant advancement in Thermo Fisher Deal

26 days ago

Verici DX announces that it has successfully transferred & received payment for a portion of the urine samples under its flagship licensing agreement with Thermo Fisher Scientific.

Belluscura poised for growth: record sales of X-PLOR and launch of DISCOV-R signal turnaround

1 month ago

Belluscura navigates challenges to showcase progress in FY23, highlighted by advances in product development, market traction, and an optimistic outlook fueled by robust sales of X-PLOR and the imminent launch of DISCOV-R.

Avacta announces key management changes and pipeline progress, eyes pure-play oncology focus

1 month ago

Avacta introduces key management changes and reports positive clinical trial progress, signaling a strategic shift towards advancing its oncology biopharma portfolio.

Belluscura reports strong interest in £2.4m placing amid record sales and upcoming DISCOV-R launch

1 month ago

Belluscura attracts significant investor interest for its proposed £2.4m placing, following last quarter's record sales numbers, and ahead of the launch of its new DISCOV-R device later this month.

Supreme acquires Clearly Drinks for £15m

1 month ago

Supreme plc has acquired Clearly Drinks Limited for £15 million, aiming to boost earnings and expand its soft drinks portfolio.

Lords poised for gains as UK construction outlook brightens

1 month ago

Lords is set to benefit from a recovering UK construction sector, leveraging its strong market position and recent acquisitions to drive growth.

Avingtrans reports stellar FY24 with record revenues and EBITDA ahead of expectations

1 month ago

Avingtrans achieves record FY24 revenue and exceeds adjusted EBITDA expectations, buoyed by strong performances in its Advanced Engineering and Medical & Industrial Imaging divisions.

Verici sign ground-breaking global licensing deal with Thermo Fisher Scientific

1 month ago

In Nov’23, expert organ transplant diagnostics firm Verici DX signed a ground breaking global licensing deal with US listed Thermo Fisher Scientific to exclusively develop an assay for pre-transplant kidney testing.

Equals extends takeover deadline amid ongoing strategic review

2 months ago

Equals' strategic review advances as Madison Dearborn explores alternatives, and a consortium of Railsr and TowerBrook Capital mulls over a potential bid, leading to an extension of the PUSU deadline to July 10th, 2024.

Belluscura reports record sales in May 2024, launches £2.4m fundraise

2 months ago

Belluscura reports significant sales growth for its portable oxygen concentrators, and proposes a £2.4m fundraising through a convertible loan note placing to support ongoing product development and market expansion.

Watchlist